NuCana PLC (NCNA)

Official site

HEALTHCARE • BIOTECHNOLOGY • NASDAQ

$1.02

-0.03 (-2.86%)

Market Cap: $4.41M

Last updated: Oct 16, 2026 at 1:55 PM ET

Earnings

Performance (10Y)

Beat Rate

63%(22/35)

Avg Surprise

+17.98%

Streak

3 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Aug 13, 2026Reported Aug 13	$-0.99	N/A	-	N/A	Beat	-	-	+95.8%
Mar 31, 2026Mar 26 Reported May 14, 2026Reported May 14	$-1.25	N/A	-	+52.72%	Beat	-	-	-143.7%
Dec 31, 2025Dec 25 Reported Mar 19, 2026Reported Mar 19	$-1.47	$-2.69	-	+45.44%	Beat	0	1 0 30d	+97.7%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.08	N/A	-	+99.38%	Beat	-	-	+100.0%
Jun 30, 2025Jun 25 Reported Aug 20, 2025Reported Aug 20	$-23.31	$-13.00	$-13.00 - $-13.00	-79.31%	Miss	0	1 0 30d	+97.0%
Mar 31, 2025Mar 25 Reported Jun 2, 2025Reported Jun 2	$-0.51	N/A	-	+96.05%	Beat	1	1 0 30d	+99.9%
Dec 31, 2024Dec 24 Reported Mar 20, 2025Reported Mar 20	$-64.85	N/A	-	+85.26%	Beat	1	1 0 30d	+81.5%
Sep 30, 2024Sep 24 Reported Nov 25, 2024Reported Nov 25	$-439.60	$-790.00	$-790.00 - $-790.00	+44.35%	Beat	1	1 0 30d	+45.5%
Jun 30, 2024Jun 24 Reported Aug 15, 2024Reported Aug 15	$-771.80	$-798.00	$-800.17 - $-795.83	+3.28%	Beat	2	No revisions (30d)	-21.1%
Mar 31, 2024Mar 24 Reported May 16, 2024Reported May 16	$-823.60	$-820.00	$-820.91 - $-819.03	-0.44%	Miss	4	No revisions (30d)	+12.0%
Dec 31, 2023Dec 23 Reported Mar 20, 2024Reported Mar 20	$-350.00	$-254.95	$-254.97 - $-254.93	-37.28%	Miss	4	No revisions (30d)	-29166566.7%
Sep 30, 2023Sep 23 Reported Nov 16, 2023Reported Nov 16	$-807.15	$-612.50	$-612.51 - $-612.48	-31.78%	Miss	4	No revisions (30d)	-51.0%
Jun 30, 2023Jun 23 Reported Aug 16, 2023Reported Aug 16	$-637.55	$-810.00	$-810.02 - $-809.98	+21.29%	Beat	4	No revisions (30d)	-51.2%
Mar 31, 2023Mar 23 Reported Apr 4, 2023Reported Apr 4	$-935.80	$-717.50	$-717.52 - $-717.49	-30.43%	Miss	3	No revisions (30d)	+6.8%
Dec 31, 2022Dec 22 Reported Mar 22, 2023Reported Mar 22	$-0.00	$-0.00	-	+0.00%	Beat	4	No revisions (30d)	+100.0%
Sep 30, 2022Sep 22 Reported Nov 16, 2022Reported Nov 16	$-534.70	$-620.00	$-620.05 - $-619.98	+13.76%	Beat	5	No revisions (30d)	+47.1%
Jun 30, 2022Jun 22 Reported Aug 17, 2022Reported Aug 17	$-421.60	$-752.50	$-755.88 - $-749.38	+43.97%	Beat	4	1 0 30d	+63.7%
Mar 31, 2022Mar 22 Reported Apr 27, 2022Reported Apr 27	$-1004.05	$-745.00	$-749.49 - $-740.49	-34.77%	Miss	4	1 0 30d	+25.3%
Dec 31, 2021Dec 21 Reported Dec 31, 2021Reported Dec 31	$-21.00	$-19.81	$-22.00 - $-18.00	-6.01%	Miss	6	No revisions (30d)	+12.5%
Sep 30, 2021Sep 21 Reported Nov 18, 2021Reported Nov 18	$-1010.45	$-1226.67	$-1229.65 - $-1225.17	+17.63%	Beat	5	No revisions (30d)	+36.4%
Jun 30, 2021Jun 21 Reported Aug 19, 2021Reported Aug 19	$-1161.40	$-1345.00	$-1345.88 - $-1344.78	+13.65%	Beat	5	No revisions (30d)	+7.3%
Mar 31, 2021Mar 21 Reported May 19, 2021Reported May 19	$-1345.00	$-1143.75	$-1146.27 - $-1142.83	-17.60%	Miss	7	No revisions (30d)	-83.1%
Dec 31, 2020Dec 20 Reported Mar 4, 2021Reported Mar 4	$-24.00	$-16.11	$-21.00 - $-12.00	-48.98%	Miss	7	No revisions (30d)	+0.0%
Sep 30, 2020Sep 20 Reported Nov 19, 2020Reported Nov 19	$-1587.55	$-1217.00	$-1220.19 - $-1211.89	-30.45%	Miss	7	No revisions (30d)	-106.0%
Jun 30, 2020Jun 20 Reported Aug 19, 2020Reported Aug 19	$-1252.85	$-1118.00	$-1119.83 - $-1114.83	-12.06%	Miss	6	No revisions (30d)	-47.4%
Mar 31, 2020Mar 20 Reported May 19, 2020Reported May 19	$-734.60	$-1149.00	$-1154.80 - $-1145.80	+36.07%	Beat	5	No revisions (30d)	+33.1%
Dec 31, 2019Dec 19 Reported Mar 10, 2020Reported Mar 10	$-24.00	$-16.20	$-18.00 - $-14.00	-48.15%	Miss	5	No revisions (30d)	-118.2%
Sep 30, 2019Sep 19 Reported Nov 13, 2019Reported Nov 13	$-770.70	$-1422.00	$-1429.20 - $-1419.20	+45.80%	Beat	5	No revisions (30d)	-51.1%
Jun 30, 2019Jun 19 Reported Aug 21, 2019Reported Aug 21	$-849.80	$-1192.00	$-1195.80 - $-1187.80	+28.71%	Beat	5	No revisions (30d)	-229.8%
Mar 31, 2019Mar 19 Reported May 14, 2019Reported May 14	$-1097.45	$-1306.67	$-1310.77 - $-1304.47	+16.01%	Beat	3	No revisions (30d)	+17.8%
Dec 31, 2018Dec 18 Reported Mar 7, 2019Reported Mar 7	$-11.00	$-19.05	$-23.00 - $-15.20	+42.26%	Beat	4	No revisions (30d)	-1406.8%
Sep 30, 2018Sep 18 Reported Oct 1, 2018Reported Oct 1	$-509.90	N/A	-	+63.61%	Beat	4	No revisions (30d)	-6798566.7%
Jun 30, 2018Jun 18 Reported Aug 28, 2018Reported Aug 28	$-257.65	N/A	-	+80.36%	Beat	3	No revisions (30d)	-183935.7%
Mar 31, 2018Mar 18 Reported May 23, 2018Reported May 23	$-1335.25	$-1092.50	-	-22.22%	Miss	-	-	-1907400.0%
Dec 31, 2017Dec 17 Reported Mar 21, 2018Reported Mar 21	$-0.73	N/A	-	+91.80%	Beat	0	No revisions (30d)	-265.0%
Sep 30, 2017Sep 17 Reported Nov 15, 2017Reported Nov 15	$-0.01	N/A	-	+87.50%	Beat	0	No revisions (30d)	-
Jun 30, 2017Jun 17 Reported Sep 29, 2017Reported Sep 29	$-0.14	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported Jun 29, 2017Reported Jun 29	$-0.07	$0.00	-	N/A	Miss	-	-	-
Dec 31, 2016Dec 16 Reported Mar 31, 2017Reported Mar 31	$-0.20	$0.00	-	N/A	Miss	-	-	-

Key Metrics

Valuation
P/E Ratio	-0.27	EV/EBITDA	N/A
Price/FCF	-0.65x	FCF Yield	-153.95%
Profitability
Profit Margin	0.00%	Operating Margin	0.00%
ROE	-70.30%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	4.73x	Quick Ratio	4.73x
Trading Statistics
Beta	2.31	Avg Volume	233.50K
52-Week High	$5.65	52-Week Low	$0.95

Technical Indicators Dashboard

Moving Averages

SMA 10$1.08

SMA 20$1.19

SMA 50$1.34

SMA 200$1.89

EMA 10$1.10

EMA 20$1.17

EMA 50$1.30

EMA 200$6.35

MACD

Line: -0.09Signal: -0.08Hist: -0.01

ADX

ADX: 20.3+DI: 15.7-DI: 25.1

Aroon & PSAR

Aroon Up56.0

Aroon Down64.0

PSAR$1.28

Bollinger Bands

Upper Band$1.42

Lower Band$0.95

%B Position3988%(Upper)

Band Width0.15

RSI (14-Day)

Neutral

32.7

Momentum Oscillators

Stoch %K18.6

Stoch %D22.5

Williams %R-85.4

ROC (10d)-12.8%

Momentum-0.15

CCI (20d)-110.0

MFI (14d)73.0

Volatility Measures

ATR (14d)$0.10(9.8%)

StdDev (20d)0.12

Hist Vol77.0%(High)

Volume Flow

VWAP$1.01

OBV5.9B

AD Line26815.7B

CMF (20d)-0.020

Volume Metrics

Avg Vol (20d)253.5K

Vol Ratio0.2x(Low)

VWMA (20d)$1.28

Pivot Points

R3$1.10

R2$1.08

R1$1.07

Pivot Point$1.05

S1$1.03

S2$1.01

S3$1.00

Advanced Oscillators

TSI-27.13

Ultimate Osc42.2

KST-209.79

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Cost of Revenue	$71,368	$69,482	$68,102	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$-71,368	$-69,482	$-68,102	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Operating Expenses	$3.38M	$4.42M	$2.74M	$779,000	$11.83M	$2.85M	$865,000	$5.32M	$8.35M	$8.27M	$9.11M	$8.25M
R&D	$2.26M	$3.21M	$1.74M	$2.17M	$7.10M	$1.73M	$729,000	$3.74M	$6.77M	$6.78M	$6.86M	$7.44M
SG&A	$1.19M	$1.57M	$1.11M	$1.40M	$4.52M	$1.07M	$540,000	$1.36M	$1.51M	$1.58M	$1.29M	$1.38M
Operating Income	$-3,454,860	$-4,418,000	$-2,806,018	$-779,000	$-11,829,000	$-2,851,000	$-865,000	$-5,323,000	$-8,352,000	$-8,269,000	$-9,107,000	$-8,252,000

Interest Income	$134,000	$143,000	$173,000	$153,000	$35,000	$25,000	$75,000	$72,000	$85,000	$126,000	$137,000	$152,000
Interest Expense	$0	$0	$0	$0	$12.61M	$0	$0	$0	$0	$0	$0	$0
Income Before Tax	$-3,430,735	$-4,275,000	$-2,592,827	$-626,000	$-24,442,000	$-2,826,000	$-790,000	$-5,251,000	$-8,267,000	$-8,143,000	$-8,970,000	$-8,100,000
Income Tax Expense	$-334,729	$-410,000	$-140,152	$-345,000	$-328,000	$-353,000	$-137,000	$-740,000	$-1,272,000	$-1,305,000	$-1,315,000	$-1,404,000

Net Income	$-3,096,005	$-3,865,000	$-2,452,675	$-281,000	$-24,114,000	$-2,473,000	$-653,000	$-4,511,000	$-6,995,000	$-6,838,000	$-7,655,000	$-6,696,000

EBITDA	$-3,383,491	$-4,713,000	$-2,737,916	$-3,502,000	$-11,558,000	$-2,725,000	$-1,154,000	$-4,959,000	$-8,142,000	$-8,228,000	$-8,004,000	$-8,668,000
EBIT	$-3,454,859	$-4,781,000	$-2,806,018	$-3,571,000	$-11,627,000	$-2,792,000	$-1,269,000	$-5,094,000	$-8,278,000	$-8,364,000	$-8,145,000	$-8,814,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about NCNA

News

NuCana won a European patent: what it means for NuCana stock

NuCana recently secured a European patent for its cancer drug candidate, NUC-7738, expanding its intellectual property protection to over 85 patents. Despite a Q2 2026 net loss of $3.08 million...

ad-hoc-news.de•Oct 15, 2026 9:39 PM ET10/15/26•Neutral

Nucana Plc ADR (NCNA-Q) Stock Price and News

This page provides real-time stock information and news updates for Nucana Plc ADR (NCNA-Q), a clinical-stage biopharmaceutical company focused on cancer treatment. The content includes stock performance data...

The Globe and Mail•Oct 7, 2026 7:41 AM ET10/7/26•Somewhat-Bullish

NuCana stock gained 2.83 percent on October 6 as patent coverage expands

NuCana stock (NCNA) saw a 2.83 percent increase on October 6, closing at USD 1.09, following an announcement that its lead cancer candidate, NUC-7738...

AD HOC NEWS•Oct 6, 2026 8:35 PM ET10/6/26•Bullish

NuCana stock falls 2.75 percent after patent update

NuCana's stock (NCNA) fell 2.75% to USD 1.06 on October 5, 2026, despite a recent European patent grant for its lead oncology candidate, NUC-7738...

AD HOC NEWS•Oct 5, 2026 7:39 PM ET10/5/26•Somewhat-Bearish

NuCana stock secures European patent protection for NUC-7738

NuCana (NCNA) has secured a European patent (EP 3683225) for the chemical structure of its drug candidate NUC-7738...

AD HOC NEWS•Sep 30, 2026 8:54 PM ET9/30/26•Bullish

NCNA Valuation and Fair Value

P/E: -0.3x
P/FCF: -0.6x
P/B: 0.2x

See GNG's fair value

NCNA Profitability: Margins, ROIC and FCF

Operating margin: 0.0%
Net margin: 0.0%
ROE: -70.3%
FCF yield: -154.0%

NCNA Competitors

Company	Ticker
Enlivex Therapeutics Ltd	ENLV
Dermata Therapeutics Inc	DRMA
Vivos Therapeutics Inc	VVOS
Liminatus Pharma, Inc. Class A Common Stock	LIMN
bioAffinity Technologies, Inc.	BIAF
Azitra Inc	AZTR
Redhill Biopharma Ltd	RDHL
Jupiter Neurosciences, Inc. Common Stock	JUNS

Sector: Healthcare

NCNA Bull Case vs Bear Case

Bull case

NCNA beat EPS estimates in 87.5% of its last 8 reported quarters.

NCNA Earnings: Beat Rate and Next Report

Beat rate: 7 of 8 quarters (87.5%)
Average surprise: 43.4%

Frequently Asked Questions About NCNA

Does NCNA pay dividends?

NuCana PLC (NCNA) does not currently pay a regular dividend.

What is NCNA's market cap?

NuCana PLC (NCNA) has a market capitalization of $4.41M with a current stock price of $1.02.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In